ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR

Approximately 3–7% of non-small cell lung cancers harbor an anaplastic lymphoma kinase (ALK) gene fusion, constituting a new molecular subtype of lung cancer that responds to crizotinib, an ALK inhibitor. Although previous studies have evaluated ALK-rearranged lung cancers, the comprehensive analysi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Li, Yuan, Pan, Yunjian, Wang, Rui, Sun, Yihua, Hu, Haichuan, Shen, Xuxia, Lu, Yongming, Shen, Lei, Zhu, Xiongzeng, Chen, Haiquan
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3724879/
https://ncbi.nlm.nih.gov/pubmed/23922677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky